Flora Peyvandi/X
Sep 29, 2025, 12:54
Microfluidic Technology Uncovers Ongoing TTP Disease Activity
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission”
Title: A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission
Authors: Adela Constantinescu-Bercu, Sabina McCann, Bertina Dragunaite, Raphael Sivera, Yishi Tan, Louisa Keogh, Karen Vanhoorelbeke, Heidi Rossmann, Bernhard Lämmle, Rens de Groot, Marie Scully
Read the full article here.
Stay updated with Hemostasis Today.
Adela Constantinescu-Bercu
Bernhard Lämmle
Bertina Dragunaite
Flora Peyvandi
Health
Heidi Rossmann
Hematology
Hemostasis
Hemostasis Today
Karen Vanhoorelbeke
Louisa Keogh
Marie Scully
Medicine
microfluidic approach
Raphael Sivera
Rens de Groot
Sabina McCann
Thrombotic thrombocytopenic purpura
Yishi Tan
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies